Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Biophore applies for DCGI approval for emergency use of Aviptadil to treat COVID-19

expresspharmaJune 15, 2021

Tag: Biophore , COVID-19 , DCGI , Aviptadil

PharmaSources Customer Service